Champions Oncology
CSBR
CSBR
25 hedge funds and large institutions have $27.6M invested in Champions Oncology in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
12% less capital invested
Capital invested by funds: $31.5M → $27.6M (-$3.93M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
84% less call options, than puts
Call options by funds: $13K | Put options by funds: $80K
Holders
25
Holding in Top 10
1
Calls
$13K
Puts
$80K
Top Buyers
| 1 | +$340K | |
| 2 | +$110K | |
| 3 | +$60.7K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$60K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$54.8K |
Top Sellers
| 1 | -$406K | |
| 2 | -$145K | |
| 3 | -$66.4K | |
| 4 |
Bank of New York Mellon
New York
|
-$19.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$10.9K |